Advertisement

Topics

ASIT biotech Presents Its Results for the First Half of 2016 and Its Recent Clinical Breakthroughs

12:01 EDT 23 Sep 2016 | FinanzNachrichten

Cash position of €19 million at end-June 2016, following the funds raised through its IPO Phase 3 clinical trial with gp-ASIT+™, the drug candidate designed to treat grass pollen rhinitis, proceed...

Original Article: ASIT biotech Presents Its Results for the First Half of 2016 and Its Recent Clinical Breakthroughs

NEXT ARTICLE

More From BioPortfolio on "ASIT biotech Presents Its Results for the First Half of 2016 and Its Recent Clinical Breakthroughs"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...